SillaJen CEO arrested on insider trading charges

Home > Business > Industry

print dictionary print

SillaJen CEO arrested on insider trading charges

SillaJen CEO Moon Eun-sang speaks in August during an emergency press conference on the failed clinical trial for Pexa-Vec. A local court issued an arrest warrant for Moon Tuesday on charges of being involved in insider trading. [YONHAP]

SillaJen CEO Moon Eun-sang speaks in August during an emergency press conference on the failed clinical trial for Pexa-Vec. A local court issued an arrest warrant for Moon Tuesday on charges of being involved in insider trading. [YONHAP]

SillaJen CEO Moon Eun-sang was arrested Tuesday on insider trading charges, after he allegedly sold millions of shares in the biopharmaceutical company just before a failed clinical trial caused the stock price to tank in August.
 
The Seoul Southern District Court issued the warrant earlier in the day, following requests from prosecutors last week that included other SillaJen executives suspected of illegally dumping shares.
 
The company's stock price plummeted in August on the news that Pexa-Vec, SillaJen's anticancer drug candidate, had failed its Phase 3 clinical trial.

 
Before the announcement, Moon had sold 2.92 million shares of SillaJen and made around 250 billion won ($204 million). Moon is also suspected of illegally increasing his control of SillaJen through a shell company in March 2014.

 
The local court previously issued arrest warrants for two former SillaJen executives in relation to the case.

 
SillaJen debuted on the secondary Kosdaq in December 2016. The Korea Exchange is expected to announce May 29 whether the company should remain on the Kosdaq after indefinitely suspending trading of SillaJen shares on May 4 in response to the allegations of criminal conduct within the company.
 
BY KO JUN-TAE   [ko.juntae@joongang.co.kr]
Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
s
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now